Barclays’s Alumis Inc ALMS Stock Holding History

Barclays’s Portfolio ALMS Stock Details ALMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,300	Closed	-$81K	–	5533
2025 Q4	$81K	Buy	+8,300	New	+$57.9K	﹤0.01%	4632

Other funds holding ALMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barclays's ALMS Position: Q1 2026 in Review

Barclays increased its Alumis Inc (ALMS) stake by 82% in Q1 2026, buying an estimated $2.51M and bringing the position to 222,658 shares worth $4.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Barclays first reported a position in ALMS in Q3 2024 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold ALMS as of Q1 2026.

Barclays held 222,658 shares of Alumis Inc worth $4.91M as of Q1 2026.
Barclays bought 100,448 Alumis Inc shares in Q1 2026, an estimated $2.51M.
Alumis Inc made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1833 holding.
Barclays first reported a position in Alumis Inc in Q3 2024 and has held it in 7 quarters since.
195 funds tracked by Wall St. Rank held Alumis Inc as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.